As shown in supplemental Table S5, high expression of CSRP2BP was associated with International Federation of Gynecology and Obstetrics (FIGO) stage (P < 0.001), type of tumour growth (P < 0.001), tumour size (P < 0.001), stromal invasion (P < 0.001), lymphovascular space invasion (LVSI) (P = 0.026) and HPV16/18 infection (P < 0.001). This evidence concerns the gene KAT14 and infection.